Abstract
Introduction

Endothelial cell apoptosis is a crucial step in the development of endothelial dysfunction and atherosclerosis. Prevention of endothelial cell death or regeneration of the damaged endothelium is an interesting option in the prevention and treatment of atherosclerotic disease. Little is known about the pathways by which endothelial regeneration in atherosclerosis is concerted. Apoptosis is associated with the release of microparticles (MP). MP are defined as vesicles shed from the cell surface of damaged cells. They carry membrane and cytoplasmic constituents from their parent cells they are released from. In addition to vessel wall derived cells such as endothelial cells, circulating cells including lymphocytes, monocytes and red blood cells release MP. Besides their role as markers of cell damage, recent reports have underlined their role as signalling elements in cell-cell communication. In this review, we focus on the emerging role of circulating cell derived MP as signalling element and transport molecule for proteins, nucleic acids and receptors in cardiovascular disease.
Microparticles
Physiologically, cells form MP during activation and aging but MP formation also occurs in pathological conditions, e.g. in response to hypoxia, irradiation, oxidative stress, exposure to proteins of the complement cascade and shear stress [1] [2] [3] [4] [5] [6] [7] [8] . MP circulate within the peripheral blood with an average concentration of 5-50 g/ml. Under steady-state conditions, roughly 80% of MP are platelet derived, 10% are endothelial derived, and another 10% are leucocyte derived [9, 10] . MP differ in size from 100 nm up to 2 m [11] . MP For a long time, the focus in MP biology was on understanding their role as an important factor in thrombosis (for review see [13] ). More recently, MPs were described to be an important mirror of the disease status and were used as a marker to quantify vessel wall damage in cardiovascular, immunological and inflammatory diseases [14] . [18] . Elevated levels of circulating MP are also seen in septic patients [6] , which might explain the procoagulant disposition of septic patients. However, the meaning of MP in septic and autoimmune conditions is not fully understood because recent research suggests that increased MP levels might be a sign of a more favourable outcome, e.g. in severe sepsis [19] . In a clinical study, Soriano [28, 29] .
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In patients with acute coronary syndromes, endothelial MP exerting CD31 and CD146 are significantly increased compared to stable CAD [30] . Moreover, EMP are equipped with oxidized phospholipids which enhance atherosclerotic progression. They are also capable of activating neutrophils and matrix metalloproteinases thereby leading to degradation of collagens and promoting plaque destabilization [31, 32] . MP taken from patients with acute coronary syndrome induced severe endothelial dysfunction in rat aorta, emphasizing their deleterious effect [33] . Leucocytederived MP (CD11a) [36] . The activation of plasminogen into plasmin takes place at the surface of EMP [37] . [39] . [40] ; third, MP shift mRNA and proteins and fourth, they are even capable of transporting whole cell organelles (Fig. 1) . [41] . MP carrying certain proteins like hedgehog proteins stemming from lymphocytes are also able to direct the differentiation of early haematopoietic cells towards a megakaryocytic differentiation [4] . Platelet-derived MP exert different surface molecules allowing attachment on endothelial cells. [42, 43] . It has been reported that MP activate endothelial cells, polymorphonuclear leucocytes and monocytes [44, 45] . Additionally, they may also induce apoptosis in leucocytes and promote secretion of cytokines and tissue factor expression in endothelial cells [46, 47] . [6, 20] 
Interestingly, EMP-induced plasmin generation modulates angiogenic properties of endothelial progenitors cells in vitro, which are believed to play a protective role in terms of atherosclerosis. Thus, a close and effective interaction between MP, endothelial cells and endothelial progenitor cells is highly likely. Platelet activation provides not only a deleterious mechanism regarding atherosclerosis and myocardial infarction but also is accompanied by the release of MP. Brill and coworkers demonstrated that MP derived from platelets possess angiogenic properties and promote post-ischemic revascularization in vitro and in vivo [38]. Leroyer and coworkers obtained similar results: MP taken from ischemic mice hind-limb muscles promoted the differentiation of bone marrow-mononuclear cells into endothelial cells in vitro and, additionally, influenced neovascularization in vivo
Own data support the interaction between EMP and regenerating endothelial cells in terms of EMP-enhanced replenishment of the damaged vessel wall (Werner et al., unpublished data). Thus, the role of EMP in cardiovascular disease not only as a marker of disease has clearly come into the focus of research. It remains unclear whether elevated MP levels in cardiovascular disease represent just a reflection of disease status or can be understood as a biological response to damage triggering further biological signals with potential favourable and/or deleterious effects. It is controversial whether vascular-protective or maladaptive properties of MP predominate but it is conceivable that MP mediate both due to various pleiotropic effects depending on the physiological process. The presented data showing the involvement of MP in angiogenesis and endothelial cell recruitment pinpoints towards a pivotal role of MP in cardiovascular disease.
Understanding microparticlesintercellular communication pathways
MP as signalling molecules
Proteins like CD41 (␣II/␤III-integrine) and CD62P (P-selectin) as well as bioactive lipids like arachidonic acid and sphingosine-1-phosphate are involved in these various biological processes mediated by platelet-derived MP
Transfer of complete receptor proteins
MP are enabled to transfer complete receptor proteins between cells. This property was observed studying platelet-derived MP that transfer adhesion molecules like CD41 from platelets to endothelial cells and to tumour cells thereby increasing their adhesiveness
